Untitled

HealthTrust presents…Virtual HTU: “Rhythm or Rate & When to Anticoagulate: Changes in 2024 AFib Guidelines”

Significant changes are proposed with the recent Atrial Fibrillation (AFib, AF) Guidelines. Previous protocols used AF classifications based on arrhythmia duration only. Atrial Fibrillation was once playfully described as the “nuisance of the ICU.” As the understanding, identification and classification of AFib has evolved, there is now a greater appreciation of the sequelae with ongoing atrial dysrhythmia. This presentation dives into how the 2024 AFib guidelines will drastically change how clinicians identify, classify and ultimately manage AF in the future. Presenters plan to share unique features of AF which support the guideline changes, and offer management tips and clinical pearls to assist clinician attendees as they approach AFib in a new way.

Learning Objectives  |  At the end of this session, participants should be able to:

1. Recall pathophysiological processes contributing to the manifestation of atrial fibrillation (AFib, AF) and management strategies in accordance with the latest AF guidelines.
2. Identify updated management strategies in treating Atrial Fibrillation that consider staging, concurrent comorbidities and individual patient factors.
3. Recognize recent evidence, guidance and interpretations of thromboembolism risk scoring and delineate clinical scenarios for initiating and discontinuing anticoagulation in Atrial Fibrillation.

Presenters:

Joseph McCoy, PharmD  |  Division Director of Clinical Pharmacy  |  HCA Healthcare Far West Division

Jeff Murawsky, M.D., FACP  |  Division Chief Medical Officer  |  Far West Division of HCA Healthcare

Target Audience:  Pharmacy & Nursing

Continuing Education Information:

• Approved for Pharmacy credit
  • Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity isTarget Audience:  Pharmacy, Nursing & Healthcare ExecutivesContinuing Education Information:
    • Approved for Pharmacy credit. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Number for this activity is 0863-9999-24-084-L01-P. The activity is approved for 1 hour of continuing education credit to Pharmacists who attend the webinar and complete the online evaluation.
    • Approved for Nursing CE. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.
    • Members who attended the live HTU event and applied for CE credit are not eligible to receive credit for the same program in a virtual format.
    • If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.